An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, Gabrielle, Hellmann, Jason, Proto, Jonathan D., Kuriakose, George, Colas, Romain A., Dorweiler, Bernhard, Connolly, E. Sander, Solomon, Robert +4 more·2016·Nature Communications
DOI 10.1038/ncomms12859

Cited by (412)

Items 301–400 of 412

  1. Modulation of the Primary Astrocyte-Enriched Cultures’ Oxylipin Profiles Reduces Neurotoxicity
    Mariia V. Guryleva, Dmitry V. Chistyakov, Alexander V. Lopachev, Sergei V. Goriainov, Alina A. Astakhova, Yulia A. Timoshina, Anastasiya V. Khutorova, Т. Н. Федорова, Marina G. Sergeeva · 2021 · Metabolites
  2. Resolvin D1 (Rvd1) Attenuates In Vitro LPS-Stimulated Inflammation Through Downregulation of miR-155, miR -146, miR -148 and Krupple Like Factor 5
    Jabar Amin Mohedin, Alireza Rezaiemanesh, Sohila Asadi, Maryam Haddadi, Bahroz Abdul Ahmed, Ali Gorgin Karaji, Farhad Salari · 2024 · Reports of Biochemistry and Molecular Biology
  3. Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis
    Wei Li, Ying Xia, Jing Yang, Arun Jayant Sanyal, Vijay H. Shah, Naga Chalasani, Qigui Yu · 2024 · Frontiers in Immunology
  4. Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: A retrospective cohort study
    Yunfei Wang, Xue-tao Zhu, Ze-ping Hu · 2025 · Prostaglandins & Other Lipid Mediators
  5. The potential of exogenous specialized pro-resolving mediators in protecting against sepsis-associated lung injury: a review
    Jiwei Shen, Huiqin Shen, Shujun Sun, Shiwen Fan, Tianhao Zhang, Guobin Song, Ning An, Xiangdong Chen, Yafen Gao · 2025 · Frontiers in Pharmacology
  6. Proresolving receptor tames inflammation in atherosclerosis
    Hebe Agustina Mena, Matthew R. Spite · 2021 · Journal of Clinical Investigation
  7. Aging and immunity: the age-old tango
    Inés Fernández-Maestre, Alexander S. Harris, Corina Amor · 2025 · Genes & Development
  8. Anti-Atherogenic Mechanisms and Therapies
    Alex Hudson, Oluwakemi Osarumwense Igiehon, Matthew D. Woolard, Arif Yurdagul · 2025 · Current Atherosclerosis Reports
  9. Oxylipins in Atherosclerosis: Their Role in Inflammation, Diagnosis, and Therapeutic Perspectives
    Dmitry V. Chistyakov, Vasiliy V. Chistyakov, Marina G. Sergeeva · 2025 · International Journal of Molecular Sciences
  10. The Role of Macrophages in Atherosclerosis: Participants and Therapists
    Xiaoyu Liu, Shuchao Pang, Yangyang Jiang, Lixin Wang, Yi Liu · 2023 · Cardiovascular Drugs and Therapy
  11. The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and the Liver of ApoE-/- Mice with Streptozocin (STZ)-Induced Type 2 Diabetes
    Huiyu Luo, Li Gan, Yu-Guo Liu, Yuanhao Wei, Junbin Chen, Xiangfu Gu, Jiaqi Tang, Yue Zhao, Chuhong Su, Lingyu Xiao et al. · 2022 · Current Issues in Molecular Biology
  12. Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice
    Anouk G. Groenen, Masharh Lipscomb, Ramon Bossardi Ramos, Sudeshna Sadhu, Venetia Bazioti, Gabrielle Fredman, Marit Westerterp · 2024 · Prostaglandins Leukotrienes and Essential Fatty Acids
  13. A Disintegrin and Metalloproteinase 17 Disrupts Bovine Macrophage MER Proto-Oncogene Tyrosine Kinase Integrity to Impede Apoptotic Cell Clearance and Promote Inflammation in Clinical Mastitis
    Jingyi Wang, Ming Li, Bi-Chen Zhao, Renxu Chang, Wenda Wu, Huijing Zhang, Muhammad Usman, Juan J. Loor, Chuang Xu · 2024 · Journal of Agricultural and Food Chemistry
  14. Exercise-Stimulated Resolvin Biosynthesis in the Adipose Tissue Is Abrogated by High-Fat Diet–Induced Adrenergic Deficiency
    Ernesto Pena Calderin, Jing‐Juan Zheng, Nolan L. Boyd, Will Lynch, Brian E. Sansbury, Matthew R. Spite, Bradford G. Hill, Jason L. Hellmann · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
  15. Plasmalogen remodeling modulates macrophage response to cytotoxic oxysterols and atherosclerotic plaque vulnerability
    Antoine Jalil, Thomas Pilot, Thibaut Bourgeois, Aline Laubriet, Xiaoxu Li, Marc Diedisheim, Valérie Deckert, Charlène Magnani, Naïg Le Guern, Jean-Paul Paı̈s de Barros et al. · 2025 · Cell Reports Medicine
  16. Potential and Future Therapeutic Applications of Eicosapentaenoic/Docosahexaenoic Acid and Probiotics in Chronic Low-Grade Inflammation
    Amedeo Amedei, Ingrid Lamminpää, Cinzia Parolini · 2025 · Biomedicines
  17. Associations Between Resolvin D1 and Culprit Plaque Morphologies: An Optical Coherence Tomography Study in Patients with ST-Segment Elevation Myocardial Infarction
    Runzhen Chen, Jiannan Li, Zhaoxue Sheng, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Nan Li, Weida Liu, Chen Liu, Peng Zhou et al. · 2023 · Journal of Inflammation Research
  18. Dietary docosahexaenoic acid supplementation inhibits acute pulmonary transcriptional and autoantibody responses to a single crystalline silica exposure in lupus-prone mice
    Preeti Chauhan, Abby D. Benninghoff, Olivia K. Favor, James G. Wagner, Ryan P. Lewandowski, Lichchavi Dhananjaya Rajasinghe, Quan‐Zhen Li, Jack R. Harkema, James J. Pestka · 2024 · Frontiers in Immunology
  19. Role of cardiolipin in regulating and treating atherosclerotic cardiovascular diseases
    Wei Jin, Meng Zhang, Xia Wang, Kaiying Yang, Qi Xiao, Xiaoyan Zhu, Xudong Pan · 2024 · European Journal of Pharmacology
  20. Serum fatty acid profiles in systemic lupus erythematosus and patient reported outcomes: The Michigan Lupus Epidemiology & Surveillance (MILES) Program
    Kristen N. Gilley, Jenifer I. Fenton, Suzanna Maria Zick, Kexin Li, Lu Wang, Wendy Marder, W. Joseph McCune, Raghav Jain, Sidney J. Herndon-Fenton, Afton L. Hassett et al. · 2024 · Frontiers in Immunology
  21. Synthesis of Two Stereoisomers of Potentially Bioactive 13,19,20-Trihydroxy Derivative of Docosahexaenoic Acid
    Narihito Ogawa, Shinsaku Sone, Song Hong, Yan Lu, Yuichi Kobayashi · 2020 · Synlett
  22. Novel Mechanisms of Ozone-Induced Pulmonary Inflammation and Resolution, and the Potential Protective Role of Scavenger Receptor BI.
    Kymberly M. Gowdy, Brita J. Kilburg-Basnyat, Myles X. Hodge, Sky W. Reece, V Yermalitsk, Sean S. Davies, Jonathan Manke, Michael Armstrong, Nichole A. Reisdorph, Robert M. Tighe et al. · 2021 · PubMed Central
  23. Apoptosis and Efferocytosis in Inflammatory Diseases
    Chandra Agung Purnama, Anna Meiliana, Melisa Intan Barliana, Keri Lestari Dandan, Andi Wijaya · 2021 · The Indonesian Biomedical Journal
  24. Platelet-derived microvesicles modulate cytokine and lipid mediator profiles in THP-1 monocytes and macrophages
    Robert D Foulem, Maroua Mbarik, Jérémie A. Doiron, Marie‐France N Soucy, Dayana Toro-Ramirez, Florient Pecourt, David A. Barnett, Luc H. Boudreau, Marc E. Surette · 2025 · Immunology Letters
  25. Maresin 1 ameliorates myocardial ischaemia‒reperfusion injury by promoting tissue resident macrophage efferocytosis
    Xuan Sun, Yuting Feng, Yawei Zhao, Yue Cai, Zhenzhu Cao, Yu Zhang, Zhonghai Wei, Anning Du, Biao Xu · 2026 · Cardiovascular Research
  26. Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments
    Hong‐Qin Wang, Yuan Li, Lei Zhang, Mengkai Lü, Chao Li, Yunlun Li · 2025 · Current Atherosclerosis Reports
  27. Pro-resolving lipid mediators in traumatic brain injury: emerging concepts and translational approach.
    Roy A. Poblete, Marcela Arenas, Nerses Sanossian, Young‐Kwon Hong, William David Freeman, Patrick D. Lyden, Stan G. Louie · 2022 · PubMed Central
  28. Advances in Understanding Cardiovascular Disease Pathogenesis through Next-Generation Technologies
    Cyrine Ben Dhaou, Matthew L. Scott, Anthony Wayne Orr · 2024 · American Journal Of Pathology
  29. Resolving inflammation and pain of sickle cell
    Gabrielle Fredman · 2019 · Blood
  30. Molecular mechanisms underlying effects of n−3 and n−6 fatty acids in cardiovascular diseases
    Denny Joseph Manual Kollareth, Chuchun L. Chang, Hylde Zirpoli, Richard Joseph Deckelbaum · 2020 · Elsevier eBooks
  31. Inflammatory Molecular Mediators and Pathways Involved in Vascular Aging and Stroke: A Comprehensive Review
    Amro Mohamed Soliman, Srijit Das, Pasuk Mahakkanukrauh · 2021 · Current Medicinal Chemistry
  32. Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
    Insha Zahoor, Jeffrey Waters, Nasar Ata, Indrani Datta, Theresa L. Pedersen, Mirela Cerghet, Laila Poisson, Silva Markovic‐Plese, Ramandeep Rattan, Ameer Y. Taha et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications
    Babunageswararao Kanuri, Krishna Prahlad Maremanda, Dipanjan Chattopadhyay, M. Faadiel Essop, Man K.S. Lee, Andrew James Murphy, Prabhakara R. Nagareddy · 2025 · Comprehensive physiology
  34. Nanotechnology for the treatment of atherosclerosis: Strategies, practical applications and future perspectives
    Ying Zhang, Zheng Chai, Ming Chen, Shufen Li, Weihua Zhuang, Walter W. Hu, Mao Chen · 2025 · Precision medicine and engineering.
  35. Endogenous antiinflammatory and proresolving lipid mediators in renal disease
    Ross Doyle, Catherine Godson · 2021 · Elsevier eBooks
  36. Identification of Important Genes Associated with the Development of Atherosclerosis
    Stanislav Nikolaevich Kotlyarov · 2023 · Current Gene Therapy
  37. Crystalline silica-induced pulmonary inflammation and autoimmunity in mature adult NZBW/f1 mice: age-related sensitivity and impact of omega-3 fatty acid intervention
    Lauren K. Heine, Tasha Scarlett, James G. Wagner, Ryan P. Lewandowski, Abby D. Benninghoff, Ashleigh N. Tindle, Anna E. Skedel, Jack R. Harkema, James J. Pestka · 2024 · Inhalation Toxicology
  38. Maresin2 negatively regulates DC’s maturation via the MAPK/NF-κB pathway in DCs
    Chaoqun Wang, Jiewen Deng, Zhengping Ding, Huan Zhu, Zhenhong Guo, Jin‐Jian Lu · 2024 · International Immunopharmacology
  39. Immunology of atherosclerosis: problems and prospects of immunotherapy
    Stanislav Nikolaevich Kotlyarov · 2025 · Vessel Plus
  40. Fine-tuning inflammation-resolution programs
    Gabrielle Fredman, Sudeshna Sadhu, Nicholas Rymut · 2016 · Current Opinion in Clinical Nutrition & Metabolic Care
  41. Resolvin D1 attenuates acid-induced DNA damage in esophageal epithelial cells and rat models of acid reflux
    Ye Zhao, Teng Ma, Zhihan Zhang, Xi Chen, Chunhua Zhou, Ling Zhang, Duowu Zou · 2021 · European Journal of Pharmacology
  42. Specialized Pro-Resolving Mediators Reduce Scarring After Cleft Lip Repair
    Evangelos Papathanasiou, Andrew R. Scott, Carroll Ann Trotman, Corinna Beale, Lori Lyn Price, Gordon S. Huggins, Yang Zhang, Irene Georgakoudi, Thomas E. Van Dyke · 2022 · Frontiers in Immunology
  43. P2X7-CaMKII drives 5-LOX nuclear translocation to impair microglial function after subarachnoid hemorrhage
    Peng-Fei Ding, Jia-Tong Zhang, Xiao-Long Zhu, Yue Cui, Chunlei Chen, Xun-Zhi Liu, Jun-Da Shen, Le-Xuan Zou, Yue Lu, Zong Zhuang et al. · 2025 · Journal of Neuroinflammation
  44. Interplay between lipid metabolism and macrophage dynamics in ischemic stroke: From mechanistic insights to therapeutic strategies.
    Jia-Gui Huang, Heng Yang, Li Zhong, Yan He, Qin Yang · 2025 · International Immunopharmacology
  45. Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications
    Neha Gupta, Yu Liu, Bishuang Cai · 2026 · ImmunoHorizons
  46. Lipid and smooth muscle architectural pathology in the rabbit atherosclerotic vessel wall using Q-space cardiovascular magnetic resonance
    Erik N. Taylor, Nasi Huang, Sunni Lin, Farzad Mortazavi, Van Jay Wedeen, Jamila H. Siamwala, Russell Gilbert, James A. Hamilton · 2022 · Journal of Cardiovascular Magnetic Resonance
  47. Cholesterol Metabolism in Atherosclerosis Development
    Young‐Hwa Goo · 2018 · Elsevier eBooks
  48. Resolvin D1-mediated cellular crosstalk protects against MASH
    Amaia Navarro‐Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Bruno Cogliati, Jerry E. Chipuk, Oren Rom, Scott L. Friedman, Brian E. Sansbury et al. · 2025 · JHEP Reports
  49. Modulation of Neutrophil Recruitment and Inflammatory Signaling in Acute Respiratory Distress Syndrome by Leukotriene Inhibitors Montelukast and Zileuton
    Anna Biedritzky, Yi Zhang, Anika Fuhr, Carolin Kleinmaier, Jutta Gamper‐Tsigaras, Ka‐Lin Heck‐Swain, Kristian‐Christos Ngamsri, Franziska M. Konrad, Michael Koeppen · 2025 · The FASEB Journal
  50. Atherothrombose
    Oliver Soehnlein · 2017 · Herz
  51. Atherosclerosis
    Walter Gottlieb Land · 2020 · Springer eBooks
  52. LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases
    Anne‐Sofie Johansson, Jesper Z. Haeggström, Jan E.W. Palmblad · 2026 · Scandinavian Journal of Immunology
  53. From anti-inflammation to pro-resolution: a new paradigm for specialized pro-resolving mediators in regulating neuroinflammation and repair after cerebral ischemia-reperfusion
    X L Wang, Hang Chen, Yan Xu, Hongtao Cui, Fang Liu · 2026 · Frontiers in Immunology
  54. Relationship Between Specialized Pro-resolving Mediators and Inflammatory Markers in Chronic Cardiac Disorders
    Malinalli Brianza-Padilla, Rafael Bojalil · 2019 · Advances in experimental medicine and biology
  55. Polyunsaturated Fatty Acid-Derived Lipid Mediators as Biomarkers in Critical Care
    Behram Khan, Andie O’Laughlin, Apostolos Perelas, Thomas H. Thatcher, Peter Jackson · 2023 · Biomarkers in disease
  56. The Changing Face of Atherosclerosis
    Anna Meiliana, Andi Wijaya · 2023 · The Indonesian Biomedical Journal
  57. Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice
    Katherine Keever, Bardia Askari · 2024 · Current Research in Pharmacology and Drug Discovery
  58. Resolution to Inflammation: Its Role in Reducing Fibrosis and Tissue Repair
    Anna Meiliana, Andi Wijaya · 2023 · The Indonesian Biomedical Journal
  59. Resolving acute inflammation; what happens when inflammation goes haywire? How can it get back in line?
    Chiara Cecconello, Pol Claria-Ribas, Lucy Victoria Norling · 2022 · Elsevier eBooks
  60. Profiling of lipid mediators in atherosclerotic carotid plaques from type 2 diabetic and non-diabetic patients.
    Louise Ménégaut, Aline Laubriet, Valentin Crespy, Maxime Nguyen, Jean‐Michel Petit, Georges Tarris, Thomas Pilot, Alexis Varin, Hélène Choubley, Victoria Bergas et al. · 2022 · Prostaglandins Leukotrienes and Essential Fatty Acids
  61. Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease
    Alessandro Mattè, Enrica Federti, Antonio Recchiuti, Moayed Hamza, Giulia Ferri, Veronica Riccardi, Jacopo Ceolan, Alice Passarini, Filippo Mazzi, Angela Siciliano et al. · 2023 · Haematologica
  62. Helpful inflammation turned harmful in non-communicable diseases
    Lucy Victoria Norling, Ganesh V. Halade · 2022 · Current Opinion in Pharmacology
  63. Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque Necrosis
    Masharh Lipscomb, Sean Walis, Michael Marinello, Hebe Agustina Mena, Matthew R. Spite, Gabrielle Fredman · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  64. MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant injury
    Victoria Leroy, Denny Joseph Manual Kollareth, Zhenxiao Tu, Jeff Arni C. Valisno, Makena Woolet-Stockton, Biplab Kumar Saha, Amir M. Emtiazjoo, Mindaugas Rackauskas, Lyle L. Moldawer, Philip Alexander Efron et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH
    Amaia Navarro‐Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Feifei Yuan, Scott Friedman, Brian E. Sansbury, Xin Hong Huang, Bishuang Cai · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Stress-induced stenotic vascular remodeling via reduction of plasma omega-3 fatty acid metabolite 4-oxoDHA by noradrenaline
    Makoto Nishimori, Naomi Hayasaka, Kazunori Otsui, Nobutaka Inoue, Junko Asakura, Manabu Nagao, Ryuji Toh, Tatsuro Ishida, Ken‐ichi Hirata, Tomoyuki Furuyashiki et al. · 2024 · Scientific Reports
  67. Exploring the nexus: Clinical and physiological correlation between cardiovascular disease and colorectal cancer
    Mohamad Bashir, Ali Murtada, Matti Jubouri, Wael Ibrahim Awad, Ian Williams, Damian Miles Bailey · 2025 · Experimental Physiology
  68. Cell apoptosis in ischemic stroke: Focus on lipid metabolism
    Rong Sun, Wenren Yang, Yuting Zhao, Fumei Zhang, Genping Wu, Aiping Wang, Ying Tian · 2025 · Neural Regeneration Research
  69. Targeting inflammation in atherosclerosis: prospects and limitations
    Dmitriy A. Tanyanskiy, Alexander D. Denisenko, Peter V. Pigarevsky · 2025 · Cytokines and inflammation
  70. Beyond cartilage degeneration: osteoarthritis as a systems failure of inflammation regulation
    David Bar‐Or, Williams, Melissa A Hausburg, Gregory W. Thomas, Raphael Bar-Or · 2026 · Frontiers in Medicine
  71. Sex Differences in Omega-3 and Omega-6 PUFA Status: A Systematic Review and Meta-analysis of Cross-Sectional Comparisons
    Dandan Li, Cherie Shum, Ariel Khoo, Tanya Shi, Miranda R. Green, Sonia Blanco Mejía, Tauseef Ahmad Khan, Laura Chiavaroli, John L. Sievenpiper, Adam H. Metherel · 2026 · Advances in Nutrition
  72. Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure
    Claire Xiao, Lucy MacDonald, Slava Epelman, Kory J. Lavine · 2026 · Immunological Reviews
  73. Phospholipase signaling in inflammation and promiscuity of phospholipase active site ligands
    Shaik Nadiya, J. Rachel Mary Clementina, Benno Susai Vijayakumar A, Thomas Jebastin, Pushparaj Annadurai, Abhinav Parashar, Daniel Andrew Gideon · 2023 · Elsevier eBooks
  74. ApoE-Knockout Mice: What are New Achievements of this Model of Atherosclerosis?
    Barbara Lorkowska-Zawicka, Jacek Jawień · 2021 · Acta Scientific Pharmaceutical Sciences
  75. Complement Factor H and Pro-Resolving Mediators Synergistically Enhance Plaque Stability in Peripheral Arterial Disease
    Eija Nissilä, Shahan Syed, Pavel Uvarov, Anna Inkeri Lokki, Mirjami Laivuori, Larisa Chernyaeva, Essi Roininen, Emilia Vataja, Antti Tuhkala, Salla Keskitalo et al. · 2025 · Research Square
  76. Los niveles de mediadores prorresolutivos no corresponden con los de mediadores inflamatorios en enfermedades isquémicas coronarias
    Rashidi Springall del Villar, Jorge Arturo Ortega-Hernandez, Luis Fernando Pérez, Fausto Sánchez‐Muñoz, Julio César Arana Martínez, Héctor González‐Pacheco, Rafael Bojalil · 2018 · Gaceta Médica de México
  77. Next-Gen Inflammation Resolution
    Gabrielle Fredman · 2020 · Circulation Research
  78. Exercise and Vascular Function
    Nicolle Kränkel, Emeline M. Van Craenenbroeck, Volker Adams · 2020 · Springer eBooks
  79. Faculty Opinions recommendation of MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity.
    Philippe Saas, Thomas Cherrier · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  80. Exacerbation of Atherosclerosis, Hyperlipidemia and Inflammation by MK-886 in Obese and Diabetic Mice
    Katherine Keever, Bardia Askari · 2022 · SSRN Electronic Journal
  81. Nanovesicles for targeting autoimmune diseases
    Rahat Andleeb, Muhammad Umar Ijaz, Asma Ashraf, Rida Rafi, Derya Karataş Yeni, Shabana Naz, Tayyaba Ali, Muhammad Asad Sajid · 2022 · Elsevier eBooks
  82. Docosahexaenoic fatty acid nanoencapsulated with Anti-PECAM-1 as strategy to increase atherosclerotic plaque stability
    Matheus de Castro Leão · 2022 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  83. Polyunsaturated Fatty Acid-Derived Lipid Mediators as Biomarkers in Critical Care
    Behram Khan, Andie E. O’Laughlin, Apostolos Perelas, Thomas H. Thatcher, Peter Jackson · 2022 · Biomarkers in disease
  84. Stress-induced vascular remodeling: novel insight into the role of omega-3 fatty acid metabolite, 4-oxoDHA
    Makoto Nishimori, Naomi Hayasaka, Kazunori Otsui, Nobutaka Inoue, Manabu Nagao, Ryuji Toh, Tatsuro Ishida, Ken‐ichi Hirata, Tomoyuki Furuyashiki, Masakazu Shinohara · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Association of serum resolvin D1 with the risk of major adverse cardiovascular events in hemodialysis patients
    Shan Jiang, C Luan, Tongtong Liu, Tengfei Xu, Jing Zhang, Peng Zhang · 2024 · International Urology and Nephrology
  86. Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
    Maria Belland Olsen, Mieke C. Louwe, Kuan Yang, Jonas Øgaard, Tuva Børresdatter Dahl, Ida Gregersen, Katrine Alfsnes, Knut Husø Lauritzen, Sarah Louise Murphy, Muhammad Shakil Ahmed et al. · 2024 · Biochemical and Biophysical Research Communications
  87. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes
    Liuyang Cheng, Jian Xia · 2025 · Metabolomics
  88. Pro-Resolving Mediator Profiles And 5-Lipoxygenase Activity In Cerebrospinal Fluid Correlate with Disease Severity and Outcome in Adults with Tuberculous Meningitis
    Romain A. Colas, Le Thanh Hoang Nhat, Nguyen Thuy Thuong-Thuong, Esteban Alberto Gomez Cifuentes, Lucy Ly, Hai Hoang Thanh, Nguyen Hoan Phu, Nguyen Thi Hoang, Guy Edward Thwaites, Jesmond Dalli · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Study the role of ASIC3 ion channels in pain hypersensitivities associated with the consumption of lipid rich diet
    Ahmed Negm · 2019
  90. Modulation de la réponse inflammatoire par les récepteurs LXRs : étude comparative entre les macrophages humains et murins dans le contexte de l’athérosclérose
    Louise Ménégaut · 2018
  91. Etude des voies de la prostaglandine E2 et des oméga-3 dans la fibrose cardiaque et dans la maladie coronarienne
    Amel Bouhadoun · 2022
  92. Resolvin D2 attenuates platelet activation and thrombosis via the GPR18 receptor
    Yang Ji, MaoJing Wang, Pin Sun, Qing Zhao, Shanglang Cai · 2026 · Biochemical and Biophysical Research Communications
  93. Transient efferocytosis-induced activation of IKKβ reprograms macrophages to promote tissue resolution in mice
    David Ngai, Saheli Chowdhury, Santosh Reddy Sukka, George Kuriakose, Brian T Havens, Mustafa Yalçınkaya, Jeremy M. Frey, Heather Doviak, Jennifer W. Bradford, Bernhard Dorweiler et al. · 2026 · Nature Communications
  94. Cytokine and Oxylipin Production in Resting and LPS‐Stimulated Monocytes From Americans of African Ancestry Are Influenced by ALOX5 Promoter Tandem Repeat Polymorphisms
    Ryan G. Snodgrass, Charles Bolt Stephensen, Patrice Armstrong, Hooman Allayee, Isabel Faria Snodgrass, Kevin D. Laugero, John W. Newman · 2026 · Mediators of Inflammation
  95. The SIRT1/STAT3 axis as a central regulator of immune, inflammatory, and lipid metabolic dysregulation in rheumatoid arthritis: therapeutic implications
    Chengzhi Cong, Yuan Wang, J S Liu · 2026 · Frontiers in Immunology
  96. The Pro-resolving Mediators of Inflammation
    Iliyan Vlasakov, Robert Nshimiyimana · 2025 · Springer eBooks
  97. Metabolic-epigenetic axis in cardiovascular inflammatory injury: regulatory mechanisms and intervention strategies
    Xiaoyu Yu, Cong Cui, Jiyong He, Xiaoyu Guan, Zhe Zhang · 2026 · Frontiers in Cardiovascular Medicine
  98. Modulating macrophage efferocytosis: Drug delivery strategies for enhancement, mimicry, and inhibition
    Zhihua Liu, Jiahui Wu, Jiayan Lyu, Zhou Zhou, Yuan Huang · 2026 · Acta Pharmaceutica Sinica B
  99. Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis
    Zhongshan He, Yaoyao Luo, Yongjiang Li, Shuping Yang, Yingjun Fan, Yi Zhang, Shengbin Liu, Zhuoming Zhou, Chengjian Cao, Haixing Shi et al. · 2026 · Acta Pharmaceutica Sinica B
  100. The Role of Immunoresolvents in Atherosclerosis: A Mini‐Review on Their Biology and Therapeutic Opportunities
    Ramin Lotfi, Alireza Nasirifar, Hoda Rahmani, Sara Falahi, Meysam Kashiri · 2026 · Health Science Reports